A Magnan, JL Mege, M Reynaud, P Thomas, C Capo, L Garbe, B Meric, M Badier, P Bongrand and L Viard
Service de Pneumologie, CHU Nord, Marseille, France.

Bronchiolitis obliterans (BO), a common complication in lung transplant recipients, is a fibrotic process probably related to acute rejection (AR) and cytomegalovirus pneumonitis (CMVP). Because the pathogenesis of pulmonary fibrotic diseases involves activation of alveolar macrophages (AM), the present study was carried out to determine if AM were activated during AR, CMVP, and BO. Interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) were measured in 157 AM supernatants obtained from 29 transplant recipients by immunoradiometric assay. Five groups were analyzed: AR (n = 21), CMVP (n = 12), BO (n = 15), bacterial pneumonia (BP) (n = 8), and control subjects (n = 70). Cytokines were also assayed 15 d (n = 15) and 30 d (n = 9) after AR and 30 d (n = 9) after CMVP. Cytokine secretion was elevated during AR (TNF- alpha = 3,709 +/- 1,409 pg/10(6) cells, IL-6 = 5,482 +/- 2,058 pg/10(6) cells, p < 0.005), and they returned to control values within 15 d. A similar pattern was observed during CMVP (TNF-alpha = 5,000 +/- 2,773 pg/10(6) cells, IL-6 = 12,280 +/- 3,939 pg/10(6) cells, p < 0.005), and values returned to control levels within 30 d. During BP, cytokine production values were higher than control values, but to a lesser extent than in AR and CMVP (TNF-alpha = 2,502 +/- 1,072, p < 0.05; IL-6 = 3,734 +/- 1,440, p < 0.005). In contrast, cytokine secretion during BO was not statistically different from that of control subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. D. Lande, J. Patil, N. Li, T. R. Berryman, R. A. King, and M. I. Hertz Novel Insights into Lung Transplant Rejection by Microarray Analysis Proceedings of the ATS, January 1, 2007; 4(1): 44 - 51. [Abstract] [Full Text] [PDF]

				C. L. Mikols, L. Yan, J. Y. Norris, T. D. Russell, A. P. Khalifah, R. R. Hachem, M. M. Chakinala, R. D. Yusen, M. Castro, E. Kuo, et al. IL-12 p80 Is an Innate Epithelial Cell Effector That Mediates Chronic Allograft Dysfunction Am. J. Respir. Crit. Care Med., August 15, 2006; 174(4): 461 - 470. [Abstract] [Full Text] [PDF]

				T. Waldow, K. Alexiou, W. Witt, F. M. Wagner, V. Gulielmos, K. Matschke, and M. Knaut Attenuation of Reperfusion-Induced Systemic Inflammation by Preconditioning With Nitric Oxide in an In Situ Porcine Model of Normothermic Lung Ischemia Chest, June 1, 2004; 125(6): 2253 - 2259. [Abstract] [Full Text] [PDF]

				D.-J. SLEBOS, J. SCHOLMA, H. MARIKE BOEZEN, G. H. KOETER, W. VAN DER BIJ, D. S. POSTMA, and H. F. KAUFFMAN Longitudinal Profile of Bronchoalveolar Lavage Cell Characteristics in Patients with a Good Outcome after Lung Transplantation Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 501 - 507. [Abstract] [Full Text] [PDF]

				K. NOWAK, M. KAMLER, M. BOCK, J. MOTSCH, S. HAGL, H. JAKOB, and M.-M. GEBHARD Bronchial Artery Revascularization Affects Graft Recovery after Lung Transplantation Am. J. Respir. Crit. Care Med., January 15, 2002; 165(2): 216 - 220. [Abstract] [Full Text] [PDF]

				J. HIRSCH, A. ELSSNER, G. MAZUR, K. L. MAIER, I. BITTMANN, J. BEHR, M. SCHWAIBLMAIR, H. REICHENSPURNER, H. FÜRST, J. BRIEGEL, et al. Bronchiolitis Obliterans Syndrome after (Heart-)Lung Transplantation . Impaired Antiprotease Defense and Increased Oxidant Activity Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1640 - 1646. [Abstract] [Full Text]

				M. TSUCHIDA, H. WATANABE, T. WATANABE, H. HIRAHARA, M. HAGA, H. OHZEKI, J. HAYASHI, H. MIYAMURA, T. HIRONO, T. ABO, et al. Effect of Cardiopulmonary Bypass on Cytokine Release and Adhesion Molecule Expression in Alveolar Macrophages . Preliminary Report In Six Cases Am. J. Respir. Crit. Care Med., September 1, 1997; 156(3): 932 - 938. [Abstract] [Full Text] [PDF]